Japanese contract research company at Fujisawa in Kanagawa prefecture, founded in 2017, which finds starting compounds for new medicines. Uses its own binder selection technology as a screening method to identify seed compounds against difficult targets, offers an agile small molecule discovery process to pharmaceutical and biotechnology customers, and works with Japanese and international partners on early discovery projects.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen